专利检索 ap:("Steven Bushnell" OR "Alexander Michael Buko" OR "Eric Taylor Whalley" OR "Christopher Stebbins" OR "Zhenming Zhao" OR "Diego Cadavid") AND inv:"Zhenming Zhao" 第 1 页

1.

发明申请
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF 审中-公开
标题翻译：生物标志物对IFNB的治疗效果预测及其用途

公开(公告)号：US20120328567A1

公开(公告)日：2012-12-27

申请号：US13441745

申请日：2012-04-06

申请人： Steven Bushnell , Alexander Michael Buko , Eric Taylor Whalley , Christopher Stebbins , Zhenming Zhao , Diego Cadavid

发明人： Steven Bushnell , Alexander Michael Buko , Eric Taylor Whalley , Christopher Stebbins , Zhenming Zhao , Diego Cadavid

IPC分类号： C40B30/04 , A61P43/00 , A61K38/21

CPC分类号： A61K38/215 , A61K45/06 , G01N33/564 , G01N33/74 , G01N2333/52 , G01N2333/523 , G01N2333/70575 , G01N2800/101 , G01N2800/285 , G01N2800/50 , G01N2800/52

摘要： Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with relapsing-remitting multiple sclerosis (RRMS)) are disclosed.

摘要翻译： 公开了用于鉴定，评估和/或治疗具有多发性硬化症（MS）（例如，复发性多发性硬化症（RRMS）的患者）的受试者的方法，测定和试剂盒。